Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01321177 · ClinicalTrials.gov registry record · NA
An Integrated Program for the Treatment of First Episode of Psychosis
A NA study, sponsored by Northwell Health.
- Completed
- Registry status
- NA
- Development phase
- 404
- Enrollment target
NCT01321177: Completed NA study, sponsored by Northwell Health.
NCT01321177 is a NA study that has completed, run by Northwell Health. The registered enrollment target is 404 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01321177, a NA study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 404 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how services should be provided to reduce symptoms and improve life functioning for adolescents and adults who have been recently diagnosed with schizophrenia.
Primary Outcome
This scale measures psychosocial functioning and behavior in people with schizophrenia. The scale contains 21 items rated 0 (no or minimal functioning) to 6 (normal functioning). The results are reported as the total score with a range from 0 to 126. Higher scores indicate a better outcome.
Interventions
- BEHAVIORAL Integrated Treatment
- BEHAVIORAL Community Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 404 participants |
| Start Date | 2010-07 |
| Est. Completion | 2017-07 |
| Phase | NA |
What the finished NCT01321177 record still lists
NCT01321177 is an interventional study that assigns participants to a tested intervention. The registered 404 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).
The record links to 0 conditions, and to 2 interventions - of which Integrated Treatment is the first listed.
NCT01321177 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01321177 about?
NCT01321177 is a clinical study titled "An Integrated Program for the Treatment of First Episode of Psychosis". The purpose of this study is to determine how services should be provided to reduce symptoms and improve life functioning for adolescents and adults who have been recently diagnosed with schizophrenia.
What is the current status of trial NCT01321177?
This trial is currently completed. It is a NA study. The enrollment target is 404 participants. The study started on 2010-07. Estimated completion is 2017-07.
What interventions are being tested in trial NCT01321177?
The interventions under investigation include: Integrated Treatment (BEHAVIORAL), Community Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT01321177?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01321177's enrollment target sits among peer trials
404 244th of 2000 higher than 1,757 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05049057 · 404 participants · Phase 2
Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI
- NCT05611242 · 404 participants · Phase 3
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
- NCT06072612 · 404 participants · Phase 3
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- NCT05576350 · 405 participants · NA
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia